Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lisanne, Tettero"'
Autor:
Leslie van der Fits, Rineke de Jong, Karin Dijkman, Marjolein Heemskerk-van der Meer, Lisanne Tettero, Judith Bonsing, Sophie van Oort, Jan Serroyen, Marianke van Schie, Norbert Stockhofe-Zurwieden, Benoit Callendret, Roland Zahn
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-13 (2024)
Abstract Vaccination with Ad26.RSV.preF, an Adenoviral serotype 26 vector encoding RSV F protein stabilized in its prefusion conformation, has previously shown to be immunogenic and protective in RSV seropositive adults and immunogenic in seropositiv
Externí odkaz:
https://doaj.org/article/8b15c10cd47a4cbcb11b6592cfaf8b91
Autor:
Eirikur Saeland, Leslie van der Fits, Renske Bolder, Marjolein Heemskerk-van der Meer, Joke Drijver, Yolinda van Polanen, Cornelis Vaneman, Lisanne Tettero, Freek Cox, Jan Serroyen, Matthew J. Jorgensen, Johannes P. M. Langedijk, Hanneke Schuitemaker, Benoit Callendret, Roland C. Zahn
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-13 (2023)
Abstract Respiratory syncytial virus (RSV) is a leading cause of severe respiratory disease for which no licensed vaccine is available. We have previously shown that a prefusion (preF) conformation-stabilized RSV F protein antigen and an adenoviral v
Externí odkaz:
https://doaj.org/article/28de2b060bbe418f87ca844fbb52ad64
Autor:
Richard Voorzaat, Freek Cox, Daan van Overveld, Lam Le, Lisanne Tettero, Joost Vaneman, Mark J. G. Bakkers, Johannes P. M. Langedijk
Publikováno v:
Vaccines, Vol 12, Iss 3, p 294 (2024)
Human respiratory syncytial virus (RSV) poses a significant human health threat, particularly to infants and the elderly. While efficacious vaccines based on the F protein have recently received market authorization, uncertainties remain regarding th
Externí odkaz:
https://doaj.org/article/7b3cd1758c084380a03c5b0855313ad3
Autor:
Freek Cox, Eirikur Saeland, Anne Thoma, Ward van den Hoogen, Lisanne Tettero, Joke Drijver, Cornelis Vaneman, Yolinda van Polanen, Tina Ritschel, Arangassery Rosemary Bastian, Benoit Callendret, Roland Zahn, Leslie van der Fits
Publikováno v:
Vaccines, Vol 11, Iss 3, p 672 (2023)
RSV is divided into two antigenic subtypes, RSV A and RSV B, which is largely based on the variation in the G protein, while the fusion protein F is more conserved and a target for antibody-mediated neutralization. Here we evaluate the breadth of the
Externí odkaz:
https://doaj.org/article/7112a4bed99c4f7a8dfd1dd7c2cab2ec
Autor:
Eirikur, Saeland, Leslie, van der Fits, Renske, Bolder, Marjolein, Heemskerk-van der Meer, Joke, Drijver, Yolinda, van Polanen, Cornelis, Vaneman, Lisanne, Tettero, Jan, Serroyen, Hanneke, Schuitemaker, Benoit, Callendret, Johannes P M, Langedijk, Roland C, Zahn
Publikováno v:
Vaccine. 40:934-944
Respiratory Syncytial Virus (RSV) remains a leading cause of severe respiratory disease for which no licensed vaccine is available. We have previously described the derivation of an RSV Fusion protein (F) stabilized in its prefusion conformation (pre
Autor:
Eirikur Saeland, Leslie van der Fits, Renske Bolder, Marjolein Heemskerk-van der Meer, Joke Drijver, Yolinda van Polanen, Cornelis Vaneman, Lisanne Tettero, Freek Cox, Jan Serroyen, Matthew J. Jorgenssen, Johannes P.M. Langedijk, Hanneke Schuitemaker, Benoit Callendret, Roland C. Zahn
Respiratory syncytial virus (RSV) is a leading cause of severe respiratory disease for which no licensed vaccine is available. We have previously shown that a prefusion (preF) conformation– stabilized RSV F protein antigen and an adenoviral vector
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e2ff30e7138158a962ff017be187b80
https://doi.org/10.1101/2022.09.23.509196
https://doi.org/10.1101/2022.09.23.509196
Autor:
Johan W. A. Verspuij, Petra Mooij, Harmjan Kuipers, Lisanne Tettero, Jeroen Huizingh, Liesbeth Dekking, Daniella Mortier, Jeroen Tolboom, Sonja P. R. Schmit-Tillemans, Hanneke Schuitemaker, Ted Kwaks, Willy M. J. M. Bogers, Gerrit Koopman, Joan E. M. van der Lubbe, Ramon Roozendaal, Boerries Brandenburg, Roland Zahn, Wim Meijberg
Publikováno v:
npj Vaccines, 3(1):25. Nature Publishing Group
npj Vaccines, Vol 3, Iss 1, Pp 1-9 (2018)
NPJ Vaccines
npj Vaccines, Vol 3, Iss 1, Pp 1-9 (2018)
NPJ Vaccines
Seasonal vaccines are currently the most effective countermeasure against influenza. However, seasonal vaccines are only effective against strains closely related to the influenza strains contained in the vaccine. Recently a new hemagglutinin (HA) st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37afb0217a019f93d61a111b27c02f43
https://pure.amc.nl/en/publications/minihemagglutinin-vaccination-induces-crossreactive-antibodies-in-preexposed-nhp-that-protect-mice-against-lethal-influenza-challenge(7ece9426-b1a1-4714-a24c-94e3d26594c7).html
https://pure.amc.nl/en/publications/minihemagglutinin-vaccination-induces-crossreactive-antibodies-in-preexposed-nhp-that-protect-mice-against-lethal-influenza-challenge(7ece9426-b1a1-4714-a24c-94e3d26594c7).html
Autor:
Vincent Klaren, Esther J. M. Stoop, Freek Cox, Eirikur Saeland, Eric Geelen, David Adrianus Theo Zuijdgeest, Bastiaan Smal, Hans J. W. M. Korse, Martin Koldijk, Ted Kwaks, Ronald Vogels, Boerries Brandenburg, Lisanne Tettero, Wouter Koudstaal, Robert Heinz Edward Friesen, Jaap Goudsmit
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Frontiers in immunology, 7. Frontiers Media S.A.
Frontiers in Immunology
Frontiers in immunology, 7. Frontiers Media S.A.
Frontiers in Immunology
Interactions with receptors for the Fc region of IgG (Fc gamma Rs) have been shown to contribute to the in vivo protection against influenza A viruses provided by broadly neutralizing antibodies (bnAbs) that bind to the viral hemagglutinin (HA) stem.
Autor:
Katarina Radosevic, Patrick Wanningen, Martijn de Man, Jeroen Tolboom, Jaap Goudsmit, Wouter Koudstaal, Liesbeth Dekking, Xueyong Zhu, Antonietta Impagliazzo, Başak Kükrer, Lisanne Tettero, Jeroen Huizingh, Ryan M. B. Hoffman, Harmjan Kuipers, Ian A. Wilson, Michelle Wagner, Peter Lee, Wim Meijberg, Adrian Apetri, Wenli Yu, Andrew B. Ward, Fin Milder, Nick S. Laursen, Ruud van Meersbergen, Eveline Sneekes-Vriese, Johan Verspuij, Sander van Meerten, Danuta Tomkiewicz, Zhaoqing Ding, Anna Zakrzewska
Publikováno v:
Science, 349(6254), 1301-1306. American Association for the Advancement of Science
Impagliazzo, A, Milder, F, Kuipers, H, Wagner, M V, Zhu, X, Hoffman, R M B, van Meersbergen, R, Huizingh, J, Wanningen, P, Verspuij, J, de Man, M, Ding, Z, Apetri, A, Kükrer, B, Sneekes-Vriese, E, Tomkiewicz, D, Laursen, N S, Lee, P S, Zakrzewska, A, Dekking, L, Tolboom, J, Tettero, L, van Meerten, S, Yu, W, Koudstaal, W, Goudsmit, J, Ward, A B, Meijberg, W, Wilson, I A & Radošević, K 2015, ' A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen ', Science, vol. 349, no. 6254, pp. 1301-1306 . https://doi.org/10.1126/science.aac7263
Impagliazzo, A, Milder, F, Kuipers, H, Wagner, M V, Zhu, X, Hoffman, R M B, van Meersbergen, R, Huizingh, J, Wanningen, P, Verspuij, J, de Man, M, Ding, Z, Apetri, A, Kükrer, B, Sneekes-Vriese, E, Tomkiewicz, D, Laursen, N S, Lee, P S, Zakrzewska, A, Dekking, L, Tolboom, J, Tettero, L, van Meerten, S, Yu, W, Koudstaal, W, Goudsmit, J, Ward, A B, Meijberg, W, Wilson, I A & Radošević, K 2015, ' A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen ', Science, vol. 349, no. 6254, pp. 1301-1306 . https://doi.org/10.1126/science.aac7263
Flu vaccine candidate STEMs the tide Every year we need a new flu vaccine, because influenza virus constantly mutates the major target of antibodies to flu: the “head” region of the viral hemagglutinin (HA) protein. Avoiding the problem of mutati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5e966ec4eee967328572874fdaffcc
https://pure.amc.nl/en/publications/a-stable-trimeric-influenza-hemagglutinin-stem-as-a-broadly-protective-immunogen(f8e04c0c-f347-468c-81ca-21b0481e94eb).html
https://pure.amc.nl/en/publications/a-stable-trimeric-influenza-hemagglutinin-stem-as-a-broadly-protective-immunogen(f8e04c0c-f347-468c-81ca-21b0481e94eb).html